Home › Funds › STEMPOINT CAPITAL LP › MPLT

STEMPOINT CAPITAL LP position in MPLT

MAPLIGHT THERAPEUTICS INC · Health Care

STEMPOINT CAPITAL LP reported holding 106,906 shares of MPLT (MAPLIGHT THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$3.8M, representing 0.85% of its reported portfolio and ranking #39 among its reported holdings. STEMPOINT CAPITAL LP has disclosed MPLT holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)106.91K sh
Reported value held$3.83M
Portfolio Weight0.85%
First reportedQ4 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How STEMPOINT CAPITAL LP's MPLT position evolved

STEMPOINT CAPITAL LP first disclosed a stake in MPLT in Q4 2025 at 100,000 shares (US$1.8M). The position peaked in Q2 2026 at 106,906 shares, worth US$3.8M. Across 3 filings, STEMPOINT CAPITAL LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 106,906 shares valued at US$3.8M — an increase of 6,906 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 100.00K $1.76M New
Q1 2026 100.00K $2.03M Hold
Q2 2026 106.91K $3.83M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MPLT and 13F data

MPLT (MAPLIGHT THERAPEUTICS INC) is a Health Care company. 118 other funds we track also report a position in MPLT — the largest reported positions include Novo Holdings A/S (US$132.1M), FCPM III SERVICES B.V. (US$115.6M), Nan Fung Group Holdings Ltd (US$34.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MPLT

All MPLT fund holders →

FAQ

How long has STEMPOINT CAPITAL LP held MPLT?

STEMPOINT CAPITAL LP has disclosed MPLT holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is STEMPOINT CAPITAL LP's current position in MPLT?

As of Q2 2026, STEMPOINT CAPITAL LP holds 106.91K shares of MPLT (MAPLIGHT THERAPEUTICS INC), valued at $3.83M, representing 0.85% of its reported portfolio and ranking #39.

Has STEMPOINT CAPITAL LP been buying or selling MPLT?

In the latest 13F filing (Q2 2026), STEMPOINT CAPITAL LP increased its position in MPLT. The position peaked in Q2 2026 at 106.91K shares.

Which other funds hold MPLT?

Other major institutional holders of MPLT include Novo Holdings A/S, FCPM III SERVICES B.V., Nan Fung Group Holdings Ltd, among 118 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.